Results 61 to 70 of about 87,202 (109)

The interaction between kynurenine pathway, suicidal ideation and augmentation therapy with minocycline in patients with treatment-resistant depression. [PDF]

J Psychopharmacol, 2023
Nettis MA, Lombardo G, Hastings C, Zajkowska Z, Mariani N, Nikkheslat N, Sforzini L, Worrell C, Begum A, Brown M, Cleare AJ, Young AH, Pariante CM, Mondelli V.   +13 more
europepmc   +1 more source

AAV Gene Augmentation Therapy Rescues the Phenotype in the RDH5-/- Cat Model of Fundus Albipunctatus. [PDF]

Invest Ophthalmol Vis Sci
Ford LM, Sun K, Occelli LM, Enfield ME, Daruwalla A, Boyd RF, Kiser PD, Petersen-Jones SM.   +7 more
europepmc   +1 more source

Analysis of medical malpractice litigation following vertebral augmentation therapy in China from 2008 to 2018. [PDF]

Medicine (Baltimore), 2022
Hu D, Liu H, Yuan B, Gu S, Xu K, Song F, Xiao S.   +6 more
europepmc   +1 more source

Agomelatine as augmentation therapy with second-generation antipsychotics for negative symptoms of schizophrenia: An open-label randomised clinical trial and electroencephalogram-derived model for treatment response prediction. [PDF]

Gen Psychiatr
Zhou W, Liang F, Chen N, Zhang Y, Wang X, Li X, Lu D, Guo F, Yao Y, Zhu J, Shen C, Wang C, Zhang P, Zhao L, Wang Y, Han J, Li W, Wu H, Wang P, Yan Q, Zhang P, Lv Q, Yi Z.   +22 more
europepmc   +1 more source

FPN1-8C>G Polymorphism as a potential genetic modifier of iron overload in transfusion-dependent β-Thalassemia major patients receiving HbF augmentation therapy. [PDF]

Pak J Med Sci
Wadood M, Siddiqi MYJ, Nazir I, Rizwan M.   +3 more
europepmc   +1 more source

Efficacy of Antipsychotic Augmentation Therapy in Treatment-Resistant Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Shahtou A, Omara HR, Qari SA, Alqahtani RS, Alnasyan ZS, Alotaibi AE, Ali AA, Alabdulrahim JM, Naser SA, Asad N, Bagabas L, Jilani SA, Metwaly AS.   +12 more
europepmc   +1 more source

Gene augmentation therapy successfully treats mice with complete congenital stationary night blindness (cCSNB), improving retinal function and visual acuity. [PDF]

Gene Ther
Hasan N, Attaway CA, Di Paolo M, McCall MA, Gregg RG.   +4 more
europepmc   +1 more source

Mitigating the Risk of Adverse Effects Related to Augmentation Therapy for Resistant Major Depressive Disorder: A Case Report. [PDF]

Medicina (Kaunas), 2022
Amundson CJ, Knight R, Ybarra GM, Turgeon J, Bingham JM.   +4 more
europepmc   +1 more source

Gene augmentation therapy restores vision and preserves photoreceptors in a mouse model of CNGA1-retinitis pigmentosa. [PDF]

Commun Med (Lond)
Wu Y, Zhao T, Wang Y, Zhang T, Hang C, Wang Y, Liu Y, Chen Z, Chen J, Li T, Sun J, Jia H, Zhang L, Wang F, Wan X, Sun X.   +15 more
europepmc   +1 more source

Cortical Visual Mapping following Ocular Gene Augmentation Therapy for Achromatopsia. [PDF]

J Neurosci, 2021
McKyton A, Averbukh E, Marks Ohana D, Levin N, Banin E.   +4 more
europepmc   +1 more source